Similar articles for PMID: 25667285

Year	Number of Results
1998	1
2006	3
2007	3
2008	5
2009	3
2010	3
2011	4
2012	10
2013	4
2014	3
2015	11
2016	13
2017	15
2018	13
2019	11
2020	4
2021	2
2022	2
2024	0

1

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.

Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL. Horowitz NS, et al. J Clin Oncol. 2015 Mar 10;33(8):937-43. doi: 10.1200/JCO.2014.56.3106. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667285 Free PMC article.

2

Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182.

Rodriguez N, Miller A, Richard SD, Rungruang B, Hamilton CA, Bookman MA, Maxwell GL, Horowitz NS, Krivak TC. Rodriguez N, et al. Gynecol Oncol. 2013 Sep;130(3):487-92. doi: 10.1016/j.ygyno.2013.06.017. Epub 2013 Jun 17. Gynecol Oncol. 2013. PMID: 23791702

3

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study.

Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS. Rungruang B, et al. Gynecol Oncol. 2012 Jan;124(1):53-8. doi: 10.1016/j.ygyno.2011.09.024. Epub 2011 Oct 26. Gynecol Oncol. 2012. PMID: 22032836 Clinical Trial.

4

Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.

Medina-Franco H, Cortés-González R, Lambreton-Hinojosa F, Fimbres-Morales A, Vargas-Siordia JC. Medina-Franco H, et al. Ann Surg Oncol. 2017 May;24(5):1330-1335. doi: 10.1245/s10434-016-5704-3. Epub 2016 Dec 19. Ann Surg Oncol. 2017. PMID: 27995454

5

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD. Rungruang BJ, et al. Cancer. 2017 May 15;123(6):985-993. doi: 10.1002/cncr.30414. Epub 2016 Nov 16. Cancer. 2017. PMID: 27864921 Free PMC article.

6

Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.

Saitou M, Iida Y, Komazaki H, Narui C, Matsuno K, Kawabata A, Ueda K, Tanabe H, Takakura S, Isonishi S, Sasaki H, Okamoto A. Saitou M, et al. Arch Gynecol Obstet. 2015 Mar;291(3):641-6. doi: 10.1007/s00404-014-3446-7. Epub 2014 Sep 4. Arch Gynecol Obstet. 2015. PMID: 25182215

7

Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV.

Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, du Bois A. Ataseven B, et al. Gynecol Oncol. 2016 Feb;140(2):215-20. doi: 10.1016/j.ygyno.2015.12.007. Epub 2015 Dec 12. Gynecol Oncol. 2016. PMID: 26691222

8

Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.

Gasimli K, Braicu EI, Richter R, Chekerov R, Sehouli J. Gasimli K, et al. Ann Surg Oncol. 2015 Aug;22(8):2729-37. doi: 10.1245/s10434-014-4329-7. Epub 2015 Feb 12. Ann Surg Oncol. 2015. PMID: 25672560

9

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.

Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA. Olawaiye AB, et al. Gynecol Oncol. 2018 Oct;151(1):18-23. doi: 10.1016/j.ygyno.2018.07.021. Epub 2018 Aug 19. Gynecol Oncol. 2018. PMID: 30135020 Free PMC article. Clinical Trial.

10

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.

Suidan RS, Leitao MM Jr, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, Levine DA, Jewell EL, Brown CL, Abu-Rustum NR, Charlson ME, Chi DS. Suidan RS, et al. Gynecol Oncol. 2015 Aug;138(2):246-51. doi: 10.1016/j.ygyno.2015.05.034. Epub 2015 May 31. Gynecol Oncol. 2015. PMID: 26037900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year